Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-13-012077
Filing Date
2013-07-24
Accepted
2013-07-24 19:04:39
Documents
2
Period of Report
2013-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 12575
2 POWER OF ATTORNEY ex24hoffmantrust.txt EX-24 3788
  Complete submission text file 0001179110-13-012077.txt   17981
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3690
Michael & Jane Hoffman 2013 Descendants (Reporting) CIK: 0001581996 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 13984605